The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Jun 2020 16:19

RNS Number : 2747R
Polypipe Group PLC
26 June 2020
 

Polypipe Group plc (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities

The Company announces that on 26 June 2020, Martin Payne, Chief Executive Officer and a Person Discharging Managerial Responsibilities, acquired 651 Shares in lieu of dividends payable, following the exercise of the Awards granted to him on 25 April 2017 and 2 May 2018 under the Deferred Share Bonus Plan, details of which were announced on 18 June 2020.

The Company also announces that on 26 June 2020, Glen Sabin, Chief Operating Officer and a Person Discharging Managerial Responsibilities, acquired 57 Shares in lieu of dividends payable, following the exercise of the Award granted to him on 2 May 2018 under the Deferred Share Bonus Plan, details of which were also announced on 18 June 2020.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Martin Payne

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares in lieu of dividends for no consideration pursuant to the exercise of nil-cost options as follows:

Deferred Share Bonus Plan award granted on 25 April 2017 (" 2017 DSBP")

Deferred Share Bonus Plan award granted on 2 May 2018 ("2018 DSBP")

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

351 - Number of 2017 DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

300 - Number of 2018 DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

26 June 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Glen Sabin

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer/Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Polypipe Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares ("Shares") of £0.001 each in the capital of Polypipe Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Acquisition of Shares in lieu of dividends for no consideration pursuant to the exercise of nil-cost options as follows:

Deferred Share Bonus Plan ("DSBP") award granted on 2 May 2018

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

57 - Number of DSBP Shares acquired having satisfied appropriate tax and national insurance liabilities.

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

26 June 2020

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Enquiries:

Emma Versluys, Company Secretary

+44 (0) 1709 770 000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKKABDPBKDFAB
Date   Source Headline
5th Mar 201510:13 amRNSHolding(s) in Company
30th Jan 20154:57 pmRNSHolding(s) in Company
26th Jan 20155:40 pmRNSDirector Declaration
19th Dec 20143:32 pmRNSHolding(s) in Company
16th Dec 201410:43 amRNSDirector/PDMR Shareholding
15th Dec 20145:38 pmRNSHolding(s) in Company
12th Dec 20144:31 pmRNSHolding(s) in Company
2nd Dec 201412:42 pmRNSHolding(s) in Company
1st Dec 20141:56 pmRNSTransaction in Own Shares
18th Nov 20147:00 amRNSInterim Management Statement
6th Nov 20144:20 pmRNSDirector/PDMR Shareholding
5th Nov 20144:12 pmRNSHolding(s) in Company
18th Sep 20149:00 amRNSDirector/PDMR Shareholding
17th Sep 20149:40 amRNSHolding(s) in Company
8th Sep 20144:16 pmRNSDirector/PDMR Shareholding
18th Aug 20147:00 amRNSHalf Yearly Report
8th Jul 20147:00 amRNSTrading Statement
1st May 20142:10 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Apr 20148:20 amRNSEnd of Stabilisation Notice
28th Apr 20147:00 amRNSconfirms exercise of over-allotment option
16th Apr 20148:00 amRNSAdmission to Trading on the London Stock Exchange
15th Apr 201412:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
14th Apr 20142:43 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
11th Apr 20144:13 pmRNSInitial Public Offering Publication of Prospectus
11th Apr 20147:20 amRNSStabilisation Notice
11th Apr 20147:02 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.